Patient recruitment

MOTIVATE (MOdern Treatment of Inhibitor-positiVe pATiEnts with haemophilia A) Begins Patient Recruitment

Retrieved on: 
Wednesday, June 17, 2020
Health, Haemophilia, Pharmaceutical industry, Clinical trials, Haemophilia A, EudraCT, Patient recruitment, Medical research

MOTIVATE is a multicentre, investigator-initiated study to capture different approaches to the management of patients with haemophilia A and inhibitors.

Key Points: 
  • MOTIVATE is a multicentre, investigator-initiated study to capture different approaches to the management of patients with haemophilia A and inhibitors.
  • MOTIVATE is registered as a non-interventional study in the US ( NCT04023019 ) and as a low-interventional, pragmatic trial in Europe( EudraCT No.
  • Dr Sidonio commented that "It is very exciting that patient recruitment for MOTIVATE has begun.
  • We expect MOTIVATE to provide valuable insights from real-world experience of haemophilia A patients who develop inhibitors to FVIII".

Phlexglobal Providing Vital Support for COVID-19 Clinical Trials

Retrieved on: 
Tuesday, June 2, 2020
Health, Pharmaceutical industry, Clinical research, Medical research, Drug discovery, Food and Drug Administration, Clinical trials, Patient recruitment

To help meet these needs, Phlexglobal is providing specialized technology and services to fast track COVID-19 trials without compromising quality .

Key Points: 
  • To help meet these needs, Phlexglobal is providing specialized technology and services to fast track COVID-19 trials without compromising quality .
  • To date, fifteen different companies have turned to Phlexglobal for clinical or regulatory support for COVID-19 studies or submissions.
  • In the early stages of the pandemic, Phlexglobal began support for a top-20 Biotech Company engaged in a global COVID-19 clinical trial.
  • Companies engaged in drug development should contact Phlexglobal at phlexglobal.com/contact for immediate regulatory and clinical support.

COVID-19 Clinical Trials Overview Featuring 140 Companies

Retrieved on: 
Friday, May 29, 2020
Health, Medical research, Clinical research, Clinical trials, Pharmaceutical industry, Design of experiments, Patient recruitment

All major trials from 2010 to 2020 and planned trials are included in the report scope.

Key Points: 
  • All major trials from 2010 to 2020 and planned trials are included in the report scope.
  • The report includes a panorama of COVID-19 clinical trials across the globe.
  • Companies and universities focusing on COVID-19 clinical trials are analyzed along with their trial participation (trial title, trial phase and current status).
  • 1.1 COVID-19 Clinical Trials Overview, 2020
    1.2.4 Drugs under Study for COVID-19 Treatment, 2020
    6 Trial Snapshots - Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details

COVID-19 Clinical Trials Guide - Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 27, 2020
Infectious diseases, Pharmaceutical, Health, Clinical trials, Health, Clinical research, Medical research, Pharmaceutical industry, Clinical trials, Design of experiments, Patient recruitment

All major trials from 2010 to 2020 and planned trials are included in the report scope.

Key Points: 
  • All major trials from 2010 to 2020 and planned trials are included in the report scope.
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided.
  • Companies and universities focusing on COVID-19 clinical trials are analyzed along with their trial participation (trial title, trial phase and current status).
  • 1.1 COVID-19 Clinical Trials Overview, 2020
    1.2.4 Drugs under Study for COVID-19 Treatment, 2020
    6 Trial Snapshots - Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details

CISCRP Explores the Impact of COVID-19 on Clinical Research

Retrieved on: 
Tuesday, May 26, 2020
Health, Clinical research, Medical research, Pharmaceutical industry, Clinical pharmacology, Clinical trial, Design of experiments, Clinical trial registration, Patient recruitment

In light of this, CISCRP conducted a brief survey among the public and patients in April 2020 to assess the impact of the pandemic on clinical research perceptions and experiences.

Key Points: 
  • In light of this, CISCRP conducted a brief survey among the public and patients in April 2020 to assess the impact of the pandemic on clinical research perceptions and experiences.
  • Of those who have participated in clinical research, more than half (56%) are currently enrolled in a clinical trial for COVID-19.
  • Overall, awareness of clinical trials remains low as 58% had not heard of a COVID-19 clinical research study recently.
  • The Center for Information and Study on Clinical Research Participation (CISCRP) is an internationally recognized non-profit organization dedicated to educating and informing the public and patients about clinical research.

GeoMap Clinical Patient Recruitment Platform Now Guarantees Enrollment Numbers

Retrieved on: 
Tuesday, April 28, 2020
Health, Pharmaceutical industry, Clinical research, Medical research, Clinical trials, Clinical pharmacology, Design of experiments, Patient recruitment

SAN FRANCISCO, CA, Apr 28, 2020 - (ACN Newswire) - GeoMap Clinical, the award-winning digital patient recruitment platform, today announced a Patient Enrollment Guarantee, ideal for sponsors wanting guaranteed patient enrollment numbers.

Key Points: 
  • SAN FRANCISCO, CA, Apr 28, 2020 - (ACN Newswire) - GeoMap Clinical, the award-winning digital patient recruitment platform, today announced a Patient Enrollment Guarantee, ideal for sponsors wanting guaranteed patient enrollment numbers.
  • The GeoMap Platform is now offering guaranteed monthly enrollment targets for sponsors wanting to remove the risk of missing timelines due to slow or stalled enrollment.
  • The GeoMap Platform finds, screens, and then sends patients direct to sites via encrypted email - and doesn't keep their information.
  • The GeoMap Platform recruits for clinical trials in North America, Latin America, Australia, New Zealand, China, South Korea, Singapore, Thailand, and the EU.

StudyKIK Announces Casey Orvin Joining the Patient Recruitment & Technology Organization as Senior Vice President of Pharmaceutical Relationships

Retrieved on: 
Monday, May 11, 2020
Health, Pharmaceutical industry, Clinical research, Clinical trials, Medical research, Advertising, Patient recruitment, Recruitment

IRVINE, Calif., May 11, 2020 /PRNewswire-PRWeb/ --StudyKIK, a patient recruitment and clinical trial technology company announced Casey Orvin has joined the organization as it's Senior Vice President of Pharmaceutical Relationships.

Key Points: 
  • IRVINE, Calif., May 11, 2020 /PRNewswire-PRWeb/ --StudyKIK, a patient recruitment and clinical trial technology company announced Casey Orvin has joined the organization as it's Senior Vice President of Pharmaceutical Relationships.
  • "Joining StudyKIK is an opportunity to connect patients with studies while aligning site-facing experience, and I'm thrilled to join a great team.
  • StudyKIK continues to lead in patient recruitment innovations & technology which in turn has made them extremely successful in decreasing enrollment timelines."
  • StudyKIK is a patient recruitment and technology platform that was founded on patient communities on all major social media channels to increase awareness for clinical trials.

Global Brain Cancer Clinical Trials Review: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status - ResearchAndMarkets.com

Retrieved on: 
Monday, May 11, 2020
Health, Oncology, Clinical trials, Health, Clinical research, Medical research, Pharmaceutical industry, Clinical pharmacology, Design of experiments, Clinical trial, Patient recruitment, Veliparib

The "Brain Cancer Global Clinical Trials Review, H1, 2020" clinical trials has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Brain Cancer Global Clinical Trials Review, H1, 2020" clinical trials has been added to ResearchAndMarkets.com's offering.
  • The "Brain Cancer Global Clinical Trials Review, H1, 2020" report provides top line data relating to the clinical trials on Brain Cancer.
  • The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.
  • The report also provides prominent drugs for in-progress trials (based on number of ongoing trials).

Clinical Ink Study Assurance Program Waives Millions of Dollars in Change Order Fees for Ongoing Clinical Trials

Retrieved on: 
Wednesday, April 29, 2020
Health, Infectious diseases, Clinical trials, Research, Science, Pharmaceutical, Biotechnology, Health, Pharmaceutical industry, Medical research, Clinical research, Clinical trials, Clinical pharmacology, Patient recruitment, Recruitment

Clinical Ink , a global clinical trial technology company, has announced a wide-ranging Study Assurance Program to minimize financial impact of the disruption from COVID-19 on new and existing clinical trials.

Key Points: 
  • Clinical Ink , a global clinical trial technology company, has announced a wide-ranging Study Assurance Program to minimize financial impact of the disruption from COVID-19 on new and existing clinical trials.
  • The effect of global quarantines has dramatically impacted new patient recruitment and has substantially changed how existing patients participate in ongoing clinical trials.
  • Fortunately, Clinical Inks technology platform offers the broadest range of capabilities for clinical trials to succeed in a post-COVID-19 world.
  • The Clinical Ink Study Assurance Program is our way of sharing the responsibility we all have to work together in a new normal.

ClinEdge Upgrades Clinical Development Support Services to Accommodate for Flexible Study Conduct With Enhanced Home Site Service Offering

Retrieved on: 
Tuesday, April 28, 2020
Health, FDA, Technology, Hospitals, Telecommunications, Clinical trials, Pharmaceutical, Health, Clinical research, Articles, Clinical trials, Clinical pharmacology, Patient recruitment, Recruitment, Pharmaceutical industry, Contract research organization, Contract manufacturing organization

ClinEdge, a global pharmaceutical and site clinical trial solutions provider, announces a dedicated offering to support clinical development efforts as study landscape shifts due to the COVID-19 crisis.

Key Points: 
  • ClinEdge, a global pharmaceutical and site clinical trial solutions provider, announces a dedicated offering to support clinical development efforts as study landscape shifts due to the COVID-19 crisis.
  • ClinEdge has been uniquely accommodating needs for both site and pharmaceutical partners, utilizing the same central service offering that enables pharmaceutical companies and CROs to enhance study management.
  • ClinEdge, a portfolio company of ClinX, provides a full suite of clinical and outsourced business services to clinical research institutions, pharmaceutical companies, and CROs.
  • The company includes a global site network of research clinics, marketing and creative design services, patient recruitment, and patient travel services.